Analysis of the variety of effects of the tranquilizer mebicar in experimental and clinical medicine

I. E. Zimakova , A. M. Karpov , T. S. Tagirova , R. R. Salikhova , A. G. Zhilyaev

Kazan medical journal ›› 1995, Vol. 76 ›› Issue (2) : 85 -87.

PDF
Kazan medical journal ›› 1995, Vol. 76 ›› Issue (2) : 85 -87. DOI: 10.17816/kazmj97048
Theoretical and clinical medicine
research-article

Analysis of the variety of effects of the tranquilizer mebicar in experimental and clinical medicine

Author information +
History +
PDF

Abstract

The drug mebicar, which gave rise to a new class of chemicals with psychotropic activity - derivatives of bicyclic bisureas, has been experimentally studied for more than 20 years, and clinical experience with its use has been accumulating since 1979. During this short time on the scale of pharmacology, experimental substantiation and clinical confirmation of its effectiveness have been obtained in a number of ways. new indications in various fields of medicine: psychiatry, narcology, cardiology, anesthesiology, neuropathology, gynecology, gerontology, dentistry, sports medicine, etc. The versatility of the therapeutic effects of the drug has created a precedent that attracts the attention of specialists. The question arises about the fundamental possibility of such a variety of therapeutic activity of the drug and the mechanisms for its implementation.

Keywords

Kazan Medical archive

Cite this article

Download citation ▾
I. E. Zimakova, A. M. Karpov, T. S. Tagirova, R. R. Salikhova, A. G. Zhilyaev. Analysis of the variety of effects of the tranquilizer mebicar in experimental and clinical medicine. Kazan medical journal, 1995, 76(2): 85-87 DOI:10.17816/kazmj97048

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

126

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/